Humana Inc vs Abrdn Physical Platinum Shares ETF — how do they compare? Humana Inc trades at $436 (market cap $46.49B), while Abrdn Physical Platinum Shares ETF trades at $15.27 (market cap $1.93B). The key difference: Humana Inc is far larger — about 24.1× Abrdn Physical Platinum Shares ETF's market cap, and Humana Inc pays a 0.91% dividend while Abrdn Physical Platinum Shares ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Abrdn Physical Platinum Shares ETF for 42 Days on average.
| HUM | PPLT | |
|---|---|---|
Market Cap | $46.49B | $1.93B |
Volume | 2,567,704 | 1,698,523 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $409.85 | $25.23 |
52-Week Low | $163.67 | $13.73 |
Typical Hold Time | 51 Days | 42 Days |
Enterprise Value | $53.84B | — |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $431.03, up 8.71% over the past day, reflecting strong momentum following a Barclays upgrade and positive earnings beats. The stock exhibits a bullish technical trend, with support at $378 and resistance at $394. Revenue has grown steadily from $92.9B in 2022 to $129.7B in 2025, though net income margins have compressed to 0.88%. Analyst consensus is a Buy with a $457.05 price target, and recent news highlights corporate initiatives and institutional investments.
The outlook for HUM is cautiously optimistic, driven by revenue growth and analyst support, but risks include margin pressure and regulatory scrutiny. Investment opportunity lies in execution of Medicare Advantage strategies, while key risks involve competitive pressures and potential fiduciary concerns highlighted in recent shareholder notices.
PPLT, the abrdn Physical Platinum Shares ETF, trades at $15.25 with a 3.18% daily gain, though technical indicators signal a bearish trend with moving averages unanimously negative. The ETF's fundamental metrics are unavailable in standard financial databases as it tracks physical platinum rather than operating as a traditional company. Recent news highlights platinum's underperformance relative to other precious metals, with mixed signals between bearish term structure and potential seasonal recovery opportunities.
The outlook remains cautious with technical weakness offset by potential catch-up trade opportunities. Key risks include platinum supply dynamics and precious metals market volatility, while the neutral oscillator readings suggest limited near-term momentum. Investment appeal hinges on macroeconomic factors driving platinum demand rather than traditional equity fundamentals.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →